The Effect of Antiarrhythmic Drugs on the Ventricular Fibrillation Waveform by CARLISLE, EJF et al.
� 8tb ft.}uU �� �� � a-J.__ E.� c.� J J�' g9-) 
TH_E_EFFECT OF ANTI-ARRHYTHMIC DR:UQS ON THE VENTRICULAR FIBRI_LLAT_I_ON WAVEF_ORM 
E.J.F. Carlisle, J.D. Allen, W.G. Kernohan, J. Anderson, and A.A.J. Adgey. 
Regional Medical Cardiology Centre, The Royal Victoria Hospital, 
Departments of Physiology and Orthopaedic Surgery, The Queen's University, 
and Department of Electrical Engineering, University of Ulster, Belfast. 
Does pretreatment with an anti-arrhythmic agent have any effect on the 
frequency of ventricular fibrillation (VF)? 
Ventricular fibrillation was electrically induced after the i.v. 
administration of the test drug in anaesthetised greyhounds; the ECG was 
recorded on tape (lead 2 and endocardial lead). The dominant frequencies of 
consecutive periods of fibrillation were measured by Fast Fourier Transform 
Analysis performed offline (Bruel and Kjaer Spectrum Analyzer). 
Five dogs were given no drug (control group); the dominant frequency of 
lead 2 ventricular fibrillation remained at over 9 Hz for 70 secs and then 
fell in the next 20 secs to about 5 Hz. The dominant frequency of 
ventricular fibrillation recorded from the endocardium of the right 
ventricle did not fall as rapidly as in lead 2, but remained above 8 Hz for 
several minutes. 
Pretreatment with verapamil (1 mg/kg i.v.; n = 5) prevented this fall 
in frequency in the lead 2 ECG, and maintained the dominant frequency above 
10 Hz for several minutes (p < 0.01). 
Pretreatment with lignocaine (10 mg/kg i.v.; mean plasma concentration 
at time of ventricular fibrillation 5.0 + 0.5 mcg/ml; n = 5) 
significantly lowered the dominant frequencies of ventricular fibrillation 
in lead 2 during the initial 80 secs (p < 0.01), but had no additional 
effect thereafter. Verapamil significantly increased the dominant frequency 
of endocardial ventricular fibrillation (p < 0.05), while lignocaine reduced 
the dominant frequency (p < 0.05). 
Propranolol (0.4 mg/kg i.v.; plasmaconcentration 118 + 22 mcg/ml; n 
= 5) had no significant effect on the dominant frequency of ventricular 
fibrillation recorded from lead 2 or the endocardium. 
The fall in the dominant frequency of lead 2 ventricular fibrillation 
with time may be due to the intracellular accumulation of calcium, as it can 
be prevented by verapamil. Lignocaine, which blocks fast sodium channels, 
reduced the frequency of the initial ventricular fibrillation recorded from 
outside or inside the heart. Blockade of beta adrenergic receptors, had 
little effect on the frequency of ventricular fibrillation. The endocardium 
appears to be resistant to the metabolic deterioration which occurs in the 
myocardium during ventricular fibrillation. 
